Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-12T04:07:23.275Z Has data issue: false hasContentIssue false
  • English
  • Français

Familial Benign Intracranial Hypertension and Depression

Published online by Cambridge University Press:  18 September 2015

C. Edward Coffey ,
Donald R. Ross ,
E. Wayne Massey  and
C. Warren Olanow
C. Edward Coffey*
Affiliation:
Departments of Neurology and Psychiatry, Duke University Medical Center, Durham, N.C. 27710
Donald R. Ross
Affiliation:
Departments of Neurology and Psychiatry, Duke University Medical Center, Durham, N.C. 27710
E. Wayne Massey
Affiliation:
Departments of Neurology and Psychiatry, Duke University Medical Center, Durham, N.C. 27710
C. Warren Olanow
Affiliation:
Departments of Neurology and Psychiatry, Duke University Medical Center, Durham, N.C. 27710
*
Box 31090, Duke University Medical Center, Durham, N.C. 27710, 919-684-8111
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Two sisters developed benign intracranial hypertension (BIH) two weeks following the resolution of a major depressive episode. The association of BIH and a major affective disorder in genetically related individuals has not been previously reported to our knowledge. Both conditions are associated with disturbances in the hypothalamic-pituitary-adrenal axis. Falling corticosteroid levels in a resolving depression may result in impaired cerebrospinal fluid absorption and subsequent BIH.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 9 , Issue 1 , February 1982 , pp. 45 - 47
Copyright
Copyright © Canadian Neurological Sciences Federation 1982

References

REFERENCES

Bercaw, B.K., Greer, M.: 1311 RISA in benign intracranial hypertension. Neurology 1970; 20: 787–790.CrossRefGoogle Scholar
Blumberg, A.G., Klein, D.F.: Severe papilledema associated with drug therapy. Am J Psychiatry 1961; 118: 168–169.CrossRefGoogle Scholar
Buchhett, W.A., Burton, C., Haag, B., Shaw, D.: Papilledema and idiopathic intracranial hypertension. New Engl J Med 1969; 280: 938–942.CrossRefGoogle Scholar
Carroll, B.J.: Neuroendocrine function in psychiatric disorders. In: Lipton, M.A., Mimascio, A., Killam, K.F., ed. Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 487–495.Google Scholar
Carroll, B.J., Mendels, J.: Neuroendocrine regulation in affective disorders. In: Sachar, E.J., ed. Hormones, Behavior, and Psychopalhology. New York, Raven adrenal st eroids. J. Neurosurg 1963; 20: 784–786.Google Scholar
Cohn, G.A.: Pseudotumor cerebri in children secondary to administration of Press, 1976, pp 193–224.Google Scholar
Diagnostic and Statistical Manual of Mental Disorders. Third Edition. Washington DC, American Psychiatric Association, 1980.Google Scholar
Dickman, M.S., Somasundaram, M., Brzozowski, L.: Pseudotumor cerebri and hyperthyroidism. N.Y. State J Med 1980; 80: 1118–1120.Google ScholarPubMed
Greer, M.: Benign intracranial hypertension. In: Vinken, P.J. and Bruyn, G.W., ed. Handbook of Clinical Neurology. Volume 16. Amsterdam, North Holland Co., 1974, ch 4, pp 150–166.Google Scholar
Howe, J.G., Saunders, M., Clarke, P.R.R.: Familial benign intracranial hypertension. Acta Neurochirurgica 1973; 29: 173–175.CrossRefGoogle Scholar
Johnston, I.: The definition of a reduced CSF absorption syndrome: A reappraisal of benign intracranial hypertension and related conditions. Med Hypotheses 1975; 1: 10–14.CrossRefGoogle Scholar
Johnston, I., Gilday, D.L., Hendrick, E.B.: The effects of steroids and steroid withdrawal on CSF absorption: An experimental study in dogs. J Neurosurg 1975; 42: 690–695.CrossRefGoogle Scholar
Johnston, I., Paterson, A.: Benign intracranial hypertension – CSF pressure and circulation. Brain 1974,37: 301–312.CrossRefGoogle Scholar
Martins, A.N.: Resistance to drainage of cerebrospinal fluid: Clinical management and significance. J Neurol Neurosurg Psychiat 1973; 36: 313–318.CrossRefGoogle Scholar
Mendlewicz, J., Shopsin, B.: Genetic Aspects of Affective Illness. New York, SP Medical and Scientific Books, 1979, pp 10–12.Google Scholar
Neville, B.G.R., Wilson, J.: Benign intracranial hypertension following corticosteroid withdrawal in childhood. Brit Med J 1970: 3: 554–556.CrossRefGoogle ScholarPubMed
Oldstone, M.B.: Disturbance of pituitary-adrenal relationships in benign intracranial hypertension (pseudotumor cerebri). J Clin EndocrMetab 1966: 26: 1366–1369.Google Scholar
Rothner, A.D., Brust, J.C.M.: Pseudotumor cerebri: Report of a familial occurrence. Arch Neurol 1974; 30: 110–111.Google ScholarPubMed
Sachar, E.J., Hellman, L.Roffwerg, H.P., Halpern, F.S., Fukushima, D.K., Gallagher, T.F.: Disrupted 24-hour patterns of Cortisol secretion in psychotic depression. Arch Gen Psychiatry, 1973: 28: 19–24.CrossRefGoogle ScholarPubMed
Traviesa, D.C., Schwartzman, R.J., Glaser, J.S., Savino, P.: Familial benign intracranial hypertension. J Neurol Neurosurg Psychiat 1976; 39: 420–423.Google ScholarPubMed
Walker, A.E., Adamkiewitz, J.J.: Pseudotumor cerebri associated with prolonged corticosteroid therapy. J Amer Med Assc 1964; 188: 779–784.Google ScholarPubMed
Walsh, F.B., Clark, D.B., Thompson, R.S., Nicholson, D.H.: Oral contraceptives and neuroophthalmologic interest. Arch Ophthal 1965; 74: 628–640.Google ScholarPubMed
Weisberg, L.A.: Benign intracranial hypertension. Medicine 1975; 54: 197–207.CrossRefGoogle ScholarPubMed